Difficulty: Medium
Average Score: 93%
Practice
A client with acute renal injury (AKI) who weighs 50 kg and has a potassium level of 6.7 mEq/L (6.7 mmol/l) is admitted to the hospital. Which prescribed medication should the nurse administer first?
Correct answer
C
Rationale
In this scenario, the correct medication to administer first to a pediatric client with acute renal injury (AKI) and a high potassium level of 6.7 mEq/L is option C, Sodium polystyrene (Kayexalate) 15 grams PO.
Sodium polystyrene is a cation-exchange resin that works by binding to potassium in the gastrointestinal tract, leading to its removal from the body through feces. This helps lower the elevated potassium levels quickly, which is crucial in preventing life-threatening cardiac arrhythmias associated with hyperkalemia.
Option A, Sevelamer, is used to treat high phosphate levels in patients with chronic kidney disease and is not indicated for acute hyperkalemia. Option B, Epoetin alfa, is a medication used to stimulate red blood cell production and is not the priority in this situation. Option D, Calcium acetate, is used to lower phosphate levels in patients with end-stage renal disease and does not address the immediate issue of hyperkalemia.
In an educational context, it is essential to understand the pharmacological management of electrolyte imbalances, especially in pediatric patients with renal dysfunction. Prompt recognition and treatment of hyperkalemia are crucial to prevent serious complications. Nurses need to prioritize interventions based on the urgency of the situation and the potential impact on the patient's health.
Sodium polystyrene is a cation-exchange resin that works by binding to potassium in the gastrointestinal tract, leading to its removal from the body through feces. This helps lower the elevated potassium levels quickly, which is crucial in preventing life-threatening cardiac arrhythmias associated with hyperkalemia.
Option A, Sevelamer, is used to treat high phosphate levels in patients with chronic kidney disease and is not indicated for acute hyperkalemia. Option B, Epoetin alfa, is a medication used to stimulate red blood cell production and is not the priority in this situation. Option D, Calcium acetate, is used to lower phosphate levels in patients with end-stage renal disease and does not address the immediate issue of hyperkalemia.
In an educational context, it is essential to understand the pharmacological management of electrolyte imbalances, especially in pediatric patients with renal dysfunction. Prompt recognition and treatment of hyperkalemia are crucial to prevent serious complications. Nurses need to prioritize interventions based on the urgency of the situation and the potential impact on the patient's health.